Time to Converge FDA Decisions and Evidence Syntheses for Long-Acting Muscarinic Antagonists and SMART in Guidelines for the Treatment of Asthma.

Autor: Krishnan, Jerry A., Au, David H.
Předmět:
Zdroj: JAMA: Journal of the American Medical Association; 4/10/2018, Vol. 319 Issue 14, p1441-1443, 3p
Abstrakt: The authors comment on systematic reviews and meta-analyses on the management of asthma which examined the efficacy of inhaled long-acting muscarinic antagonists (LAMAs) and investigated the relative efficacy of a single maintenance and reliever therapy (SMART) strategy containing inhaled formoterol and inhaled corticosteroids. Topics covered include effect of these studies on the treatment of asthma and the need to connect the efforts of the U.S. Food and Drug Administration and study results.
Databáze: Complementary Index